Gan & Lee Pharmaceuticals Signs PDP Agreement with Brazilian Health Ministry
Gan & Lee Pharmaceuticals (SHA: 603087) announced the signing of Parcerias para o Desenvolvimento Produtivo...
Zelgen Biopharmaceuticals Submits New Indication Application for Jacktinib in Severe Alopecia Areata
China-based Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced that it has submitted a new...
Meheco Acquires Golden Harvest for E-commerce Expansion
China Meheco Group Co., Ltd (SHA: 600056) announced the acquisition of 100% stake in Beijing...
JD Healthcare Reports 25.5% Revenue Growth in Q1 2025
JD Healthcare (HKG: 6618), a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD), released its...
Ocumension Therapeutics Receives Approval for OT-703 Real-World Study in China
Chinese ophthalmology specialist Ocumension Therapeutics (HKG: 1477) announced that it has received approval in China...
Legend Biotech’s Q1 2025 Results Highlight Carvykti Sales Growth
China-based Legend Biotech Corporation (NASDAQ: LEGN) released its Q1 2025 financial report, highlighting significant revenue...
Sanyou Biopharmaceuticals and TransReco Biotechnology Partner to Advance Novel Drug Formulations
China-based Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and TransReco (Wenzhou) Biotechnology Co., Ltd. announced a strategic...
Novo Nordisk Partners with PingAn Good Doctor to Promote Scientific Weight Loss in China
Denmark-based Novo Nordisk (NYSE: NVO, CPH: NOVO-B) has formed a strategic partnership with China’s Ping...
BRL Medicine Reports Positive Results for TyU19 in Refractory SLE Trial
Shanghai-based BRL Medicine Inc. announced positive results from an investigator-initiated trial (ITT) evaluating its allogeneic...
InnoCare Pharma Partners with Westlake University for Innovative Drug Research
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) announced a strategic partnership agreement with Westlake...
Betta Pharmaceuticals Secures Macau Approval for Ensartinib
China-based Betta Pharmaceuticals (SHE: 300558) announced a market approval filing in Macau for its ensartinib,...
OYMotion Technologies Secures RMB 100 Million in Series B++ Funding for Exoskeleton Robots
Shanghai-based OYMotion Technologies Co., Ltd, a high-tech company specializing in brain-computer interface and robotics technology,...
Genentech to Invest Over $700 Million in North Carolina Drug Manufacturing Facility
Genentech, a member of the Roche Group (SWX: ROG, OTCMKTS: RHHBY), announced plans to invest...
Huadong Medicine Presents DR10624 Study Results for Obesity and Hypertriglyceridemia at EASL 2025
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced the first presentation of results from its...
Teva Announces 8% Workforce Reduction to Achieve $700 Million Cost-Saving Goal
Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has disclosed plans to reduce its workforce by...
Formosa Pharmaceuticals Signs Licensing Deal with Laboratorios Saval for APP13007
Taiwan-based Formosa Pharmaceuticals (TPE: 6838) announced a licensing agreement with Laboratorios Saval, granting the Chilean...
Hybio Partners with iCarbonX to Develop Triple Agonist for Metabolic Diseases
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced a strategic partnership with compatriot firm iCarbonX...
Tenacia Partners with TSH Biopharm for Ztalmy Commercialization in Taiwan
Tenacia Biotechnology, a central nervous system (CNS) specialist backed by Bain Capital, has entered into...
BeiGene’s Sonrotoclax Gains NMPA Priority Review for MCL Treatment
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), a China-based oncology specialist proposing to change...
United Imaging Healthcare Gains FDA Approval for uAngio AVIVA Interventional X-ray System
China-based United Imaging Healthcare (UIH, SHA: 688271) announced that it has received marketing approval from...